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Introduction 
Acute massive pulmonary haemorrhage (AMPH) 
is a rare but highly fatal complication in systemic 
lupus erythematosus (SLE) (1,2). Its pathogenic 
mechanisms can be multifactorial, including the 
deposition of immune complexes, microangiitis, pul- 
monary infection and coagulopathy (3-5). Deep vein 
thrombosis with pulmonary embolism as a complica- 
tion of SLE is also rare (6). The causes for this 
complication include lupus anticoagulant, thrombo- 
phlebitis and nephrotic syndrome (68). Varicella 
is usually self-limited and confined to the skin in a 
normal individual. An SLE patient developing 
systemic varicella and complications of deep vein 
thrombosis, pulmonary embolism and AMPH is 
described here. The role of systemic varicella in these 
complications is discussed. 
Case Report 
Our patient, a 19-year-old girl, was diagnosed in 
1987 to have SLE because of polyarthritis, malar rash 
and positive tests for antinuclear and anti-dsDNA 
antibodies. In July 1989, nephrotic syndrome devel- 
oped. Renal biopsy disclosed a picture of diffuse 
proliferative glomerulonephritis, but evidence sugges- 
tive of Goodpasture’s syndrome was lacking. She was 
treated with prednisolone (0.551 mg kg ~ i day - ‘) 
and cyclophosphamide (l-2 mg kg - ’ day - ‘) with 
much improvement. 
One month after the renal biopsy, she was admit- 
ted because of severe back pain for 1 day and the 
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appearance of bean-sized vesicles on the face and 
back for 4 days. On admission, mild leg oedema and 
ascites were found. The superficial veins on abdomen 
and chest were not engorged. Evidence of vasculitis 
or thrombophlebitis was not found. There was no 
history of protracted bed rest or usage of oral con- 
traceptives. Complete blood counts showed a haemo- 
globin level of 6.0 mmol l- ‘, white blood cell count 
of 15 x lo9 l- i and normal platelet count. Protein- 
uria (+ + +) was noted. Serum level of albumin 
was 27 g l- i; of creatinine 150pmoll~ ’ (normal 
<106pmoll-‘) and of total cholesterol 
12.56 mmol l- i. Serum concentrations of anti- 
dsDNA, C3 and C4 were all within normal limits. 
Serum lupus anticoagulant, anti-glomerular base- 
ment antibody and anti-cardiolipin antibody were 
absent. The chest X-ray was normal except for mild 
cardiomegaly. Computerized tomogram of the abdo- 
men disclosed low-density substances in the inferior 
vena cava and bilateral renal veins, indicating the 
presence of thrombi in these vessels, which appeared 
normal in the sonographic examination performed 1 
month before. All these findings and the whole 
clinical course indicated thrombosis formation a few 
days prior to this admission. She was then treated 
with prednisolone (40 mg day - ‘), acyclovir and low- 
dose heparin therapy (3000 IU, b.i.d. subcutane- 
ously). Prothrombin time and activated partial 
thromboplastin time (aPTT) were kept at l-1.5 times 
normal values. No bleeding was noted until the 
fourth hospital day when the patient developed 
haemoptysis and dyspnoea. The dyspnoea worsened 
and massive haemoptysis occurred 5 h after onset of 
haemoptysis. Complete blood count and chest 
radiography were rechecked 1 h before massive 
haemoptysis occurred. The haemoglobin level was 
2.6 mmol l- ’ lower than 1 day before. Alveolar 
infiltrations were found over the middle and lower 
lung fields on both sides. The arterial blood gas 
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Plate I Section of the lung showing haemorrhage (arrow) and embolus in the pulmonary artery (arrowhead). 
disclosed acute respiratory failure with metabolic 
acidosis (pH: 6.8, PCO,: 8.9 kPa, PO,: 9,8 kPa, CO, 
content: 9.7 mmol 1~ ‘, oxygen saturation: 72%) (on 
100% oxygen, but without ventilator). The patient 
expired 20 min after AMPH occurred. 
On autopsy, big thrombi were found in the inferior 
vena cava and bilateral renal veins. Microscopically, 
pulmonary oedema, haemorrhage and emboli in the 
small and middle-sized pulmonary arteries were dif- 
fusely seen in both lungs, but there was no alveolitis 
or interstitial pneumonitis (Plate 1). Systemic vari- 
cella involving kidney, lung, liver, pancreas, adrenal 
gland, oesophagus, vagina, ovary and skin was dis- 
closed on the immunoperoxidase staining with anti- 
herpes simplex monoclonal antibody. Thrombi in the 
renal vessels with intranuclear inclusion bodies were 
also found (Plate 2). 
Discussion 
We report an SLE patient with systemic varicella 
who subsequently developed acute deep vein throm- 
bosis, pulmonary embolism and AMPH. The clinico- 
pathological findings of pulmonary haemorrhage 
in this patient fulfilled the characteristic manifesta- 
tions of AMPH, as reported by other authors (1,2). 
Pulmonary embolism can decrease pulmonary vascu- 
lar beds and induce pulmonary arterial constriction. 
If severe enough, pulmonary arterial pressure may 
subsequently become raised (8). In our patient, 
emboli were diffusely found in both lungs; pulmonary 
arterial pressure was therefore speculated to be 
high, although there was no time for haemodynamic 
Plate 2 Section of the kidney showing thrombus (arrow- 
head) in the vessel with intranuclear inclusion body of 
varicella (arrow). 
measurement. Haemoptysis is common in patients 
with varicella pneumonia but massive pulmonary 
haemorrhage seems to be very rare (9,lO). In our 
patient, SLE-associated alveolitis or interstitial 
pneumonitis was not found on autopsy, lupus anti- 
coagulant was absent, and prothrombin time and 
aPTT were kept in the safe range when AMPH 
developed. All these findings indicated that AMPH in 
our patient was the outcome of interaction between 
varicella pneumonia, pulmonary embolism and the 
anticoagulant therapy. Both anticoagulant and 
increased pulmonary arterial pressure may have 
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transformed the pre-existing pulmonary haemor- 
rhage, caused by varicella pneumonia, into the more 
severe one. 
The temporal relationship between formation of 
deep vein thrombosis and appearance of varicella 
and the finding of thrombi in the renal vessels with 
intranuclear inclusion body, indicated that varicella 
was involved in the formation of deep vein thrombo- 
sis in our patient. Systemic varicella can be compli- 
cated by deep vein thrombosis and/or pulmonary 
embolism, although it rarely occurs (11,12). Endo- 
thelial cells infected by varicella may proliferate and 
become swollen, subsequently serving as initiating 
sites of platelet aggregation and red thrombus forma- 
tion. There is still no other report concerning vari- 
cella in the development of deep vein thrombosis or 
AMPH in SLE. 
Systemic lupus erythematosus patients may have 
a higher risk of developing systemic varicella, es- 
pecially after having been treated with immuno- 
suppressed drugs. Once it occurs, treatment must be 
given aggressively and as early as possible so that 
deep vein thrombosis and pulmonary haemorrhage 
may thus be prevented. In the presence of varicella 
pneumonia and pulmonary embolism, anticoagulant 
should be cautiously administered to avoid the 
occurrence of AMPH. 
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